NSIM
BLCM

North Star Investment Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

North Star Investment Management’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1
Closed – – 1326
2023
Q1 		$0 Hold
1
– – ﹤0.01% 1342
2022
Q4 		$1 Hold
1
– – ﹤0.01% 1313
2022
Q3 		$0 Hold
1
– – ﹤0.01% 1195
2022
Q2 		$0 Hold
1
– – ﹤0.01% 1197
2022
Q1 		$0 Hold
1
– – ﹤0.01% 1233
2021
Q4 		$0 Hold
1
– – ﹤0.01% 1230
2021
Q3 		$0 Hold
1
– – ﹤0.01% 1152
2021
Q2 		$0 Hold
1
– – ﹤0.01% 1125
2021
Q1 		$0 Buy
+1
New +$4 ﹤0.01% 1095

Other funds holding BLCM

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
PGAM
Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

North Star Investment Management's BLCM Position: Q2 2023 in Review

North Star Investment Management sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q2 2023, closing a stake of 1 share.

North Star Investment Management first reported a position in BLCM in Q1 2021 and held it in 9 quarters. The position peaked at $1 in Q4 2022. 4 funds tracked by Wall St. Rank hold BLCM as of Q2 2023.

  • North Star Investment Management reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • North Star Investment Management sold 1 Bellicum Pharmaceuticals, Inc. share in Q2 2023.
  • North Star Investment Management first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2021 and held it in 9 quarters.
  • North Star Investment Management's Bellicum Pharmaceuticals, Inc. position peaked at $1 in Q4 2022.
  • 4 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q2 2023.

Based on North Star Investment Management's 13F filing for Q2 2023, filed 2 Aug 2023.